Showing results (791-800 of 815) with videos related to
Sort By:
Pageof 82
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 9, 2010
Effects of magnetic nanoparticle of Fe3O4 on apoptosis induced by Gambogic acid in U937 leukemia cellsYi-Qiong Liang, Bao-An Chen, Wei-Wei Wu, et al.Acta Pharmacologica Sinica|January 14, 2021
A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritisYu-Ting Liu, Hui-Hua Ding, Ze-Min Lin, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 9, 2010
[Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines]Fei Wang, Bao-An Chen, Jian Cheng, et al.Chinese Journal of Integrative Medicine|May 27, 2024
Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World StudyNi-da Cao, Xiao-Hong Zhu, Fang-Qi Ma, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 14, 2025
Circulating HMGB2 Is Associated With Angiographic Coronary Collateralization in Diabetic Patients With Chronic Total Occlusion and Impairs Vessel Growth via NLRP3Zhi Ming Wu, Shuai Chen, Yang Dai, et al.The Journal of Pathology|March 3, 2025
Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasiaEmily H Green, Subhag R Kotrannavar, Megan E Rutherford, et al.Acta Pharmacologica Sinica|January 27, 2015
Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patientsPing Feng, De-min Yu, Li-ming Chen, et al.Journal of Cellular and Molecular Medicine|February 23, 2021
KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulationYu-Shui Ma, Ting-Miao Wu, Bin Qian, et al.Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.Journal of Cancer Research and Clinical Oncology|July 8, 2019
A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patientsFeng Li, Fu-Sheng Yao, Xi-Jun Zhu, et al.Pageof 82